Screener
Design Therapeutics, Inc. DSGN Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Change in operating assets and liabilities: | ||
| Prepaid expense and other assets | (287) | (1,407) |
| Accounts payable and other liabilities | (2,511) | (301) |
| Net cash used in operating activities | (16,431) | (16,789) |
| Cash flows from investing activities | ||
| Purchases of investment securities | (52,589) | (86,548) |
| Proceeds from maturities of investment securities | 45,000 | 94,490 |
| Purchases of property and equipment | — | (72) |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s operating cash flow?
- Design Therapeutics, Inc. (DSGN) reported operating cash flow of -$16.43M in Q1 2026.
- How has Design Therapeutics, Inc.'s operating cash flow changed year-over-year?
- Design Therapeutics, Inc.'s operating cash flow increased by 2.1% year-over-year, from -$16.79M to -$16.43M.
- What is the long-term trend for Design Therapeutics, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s operating cash flow has grown at a 16.6% compound annual growth rate (CAGR), from -$29.38M to -$54.36M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Design Therapeutics, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude